Conference report: Trends, new technologies and implications for dementia diagnostics, treatment and care in Switzerland.

IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Julius Popp, Reto W Kressig, Mélanie Bieler-Aeschlimann, Miriam Rabl, Marcello Ienca, Andreas U Monsch, Hans Pihan, Stefan Klöppel, Tatjana Meyer-Heim, Stefanie Becker
{"title":"Conference report: Trends, new technologies and implications for dementia diagnostics, treatment and care in Switzerland.","authors":"Julius Popp, Reto W Kressig, Mélanie Bieler-Aeschlimann, Miriam Rabl, Marcello Ienca, Andreas U Monsch, Hans Pihan, Stefan Klöppel, Tatjana Meyer-Heim, Stefanie Becker","doi":"10.57187/s.4017","DOIUrl":null,"url":null,"abstract":"<p><p>Dementia diseases represent a major burden for the directly affected people, their relatives and modern society. Despite considerable efforts in recent years, early and accurate disease diagnosis and monitoring is still a challenge while no cure is available in most cases. New drugs, in particular disease-modifying therapies, and recent technological advancements offer promising perspectives. The integration of novel biomarkers, artificial intelligence and digital health tools has the potential to transform dementia care, making it more personalised, efficient and adapted to the living conditions and needs of older people. In November 2023, the 7th Dementia Summit convened a panel of experts from geriatrics, neurology, neuropsychology, psychiatry, ethics as well as general medicine to discuss interdisciplinary challenges, advancements and their implications for the future of dementia care in Switzerland. The conference underscored the importance of a multidisciplinary approach to successfully integrate new technologies in both clinical-translational research and dementia prevention, diagnosis and care. While recent innovations represent major steps forward, their implementation also comes with important challenges including questions on healthcare system preparedness and adaptation, ethical aspects, technology literacy, acceptance and appropriate use.</p>","PeriodicalId":22111,"journal":{"name":"Swiss medical weekly","volume":"155 ","pages":"4017"},"PeriodicalIF":2.1000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss medical weekly","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.57187/s.4017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Dementia diseases represent a major burden for the directly affected people, their relatives and modern society. Despite considerable efforts in recent years, early and accurate disease diagnosis and monitoring is still a challenge while no cure is available in most cases. New drugs, in particular disease-modifying therapies, and recent technological advancements offer promising perspectives. The integration of novel biomarkers, artificial intelligence and digital health tools has the potential to transform dementia care, making it more personalised, efficient and adapted to the living conditions and needs of older people. In November 2023, the 7th Dementia Summit convened a panel of experts from geriatrics, neurology, neuropsychology, psychiatry, ethics as well as general medicine to discuss interdisciplinary challenges, advancements and their implications for the future of dementia care in Switzerland. The conference underscored the importance of a multidisciplinary approach to successfully integrate new technologies in both clinical-translational research and dementia prevention, diagnosis and care. While recent innovations represent major steps forward, their implementation also comes with important challenges including questions on healthcare system preparedness and adaptation, ethical aspects, technology literacy, acceptance and appropriate use.

会议报告:瑞士痴呆症诊断、治疗和护理的趋势、新技术和影响。
痴呆症对直接受影响的人、他们的亲属和现代社会来说是一个重大负担。尽管近年来作出了相当大的努力,但早期和准确的疾病诊断和监测仍然是一个挑战,而在大多数情况下无法治愈。新药,特别是疾病修饰疗法和最近的技术进步提供了有希望的前景。新型生物标志物、人工智能和数字健康工具的整合有可能改变痴呆症护理,使其更加个性化、高效,并适应老年人的生活条件和需求。2023年11月,第七届痴呆症峰会召集了来自老年病学、神经病学、神经心理学、精神病学、伦理学和全科医学的专家小组,讨论了跨学科的挑战、进展及其对瑞士痴呆症护理未来的影响。会议强调了在临床转化研究和痴呆预防、诊断和护理中成功整合新技术的多学科方法的重要性。虽然最近的创新取得了重大进展,但它们的实施也面临着重大挑战,包括卫生保健系统的准备和适应、道德方面、技术素养、接受和适当使用等问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Swiss medical weekly
Swiss medical weekly 医学-医学:内科
CiteScore
5.00
自引率
0.00%
发文量
0
审稿时长
3-8 weeks
期刊介绍: The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信